219 related articles for article (PubMed ID: 31941842)
1. Nrf2 activation protects against lithium-induced nephrogenic diabetes insipidus.
Jobbagy S; Vitturi DA; Salvatore SR; Pires MF; Rowart P; Emlet DR; Ross M; Hahn S; St Croix C; Wendell SG; Subramanya AR; Straub AC; Tan RJ; Schopfer FJ
JCI Insight; 2020 Jan; 5(1):. PubMed ID: 31941842
[TBL] [Abstract][Full Text] [Related]
2. Lithium-induced NDI: acetazolamide reduces polyuria but does not improve urine concentrating ability.
de Groot T; Doornebal J; Christensen BM; Cockx S; Sinke AP; Baumgarten R; Bedford JJ; Walker RJ; Wetzels JFM; Deen PMT
Am J Physiol Renal Physiol; 2017 Sep; 313(3):F669-F676. PubMed ID: 28615247
[TBL] [Abstract][Full Text] [Related]
3. Hydrochlorothiazide attenuates lithium-induced nephrogenic diabetes insipidus independently of the sodium-chloride cotransporter.
Sinke AP; Kortenoeven ML; de Groot T; Baumgarten R; Devuyst O; Wetzels JF; Loffing J; Deen PM
Am J Physiol Renal Physiol; 2014 Mar; 306(5):F525-33. PubMed ID: 24352504
[TBL] [Abstract][Full Text] [Related]
4. Acetazolamide Attenuates Lithium-Induced Nephrogenic Diabetes Insipidus.
de Groot T; Sinke AP; Kortenoeven ML; Alsady M; Baumgarten R; Devuyst O; Loffing J; Wetzels JF; Deen PM
J Am Soc Nephrol; 2016 Jul; 27(7):2082-91. PubMed ID: 26574046
[TBL] [Abstract][Full Text] [Related]
5. Lithium induces aerobic glycolysis and glutaminolysis in collecting duct principal cells.
Alsady M; de Groot T; Kortenoeven MLA; Carmone C; Neijman K; Bekkenkamp-Grovenstein M; Engelke U; Wevers R; Baumgarten R; Korstanje R; Deen PMT
Am J Physiol Renal Physiol; 2018 Feb; 314(2):F230-F239. PubMed ID: 29070571
[TBL] [Abstract][Full Text] [Related]
6. Metabolic reprogramming of renal epithelial cells contributes to lithium-induced nephrogenic diabetes insipidus.
Liu M; Deng M; Luo Q; Sun P; Liang A; Li X; Luo X; Pan J; Zhang W; Mo M; Guo X; Dou X; Jia Z
Biochim Biophys Acta Mol Basis Dis; 2023 Oct; 1869(7):166765. PubMed ID: 37245528
[TBL] [Abstract][Full Text] [Related]
7. Role of adenylyl cyclase 6 in the development of lithium-induced nephrogenic diabetes insipidus.
Poulsen SB; Kristensen TB; Brooks HL; Kohan DE; Rieg T; Fenton RA
JCI Insight; 2017 Apr; 2(7):e91042. PubMed ID: 28405619
[TBL] [Abstract][Full Text] [Related]
8. Hyperactivation of Nrf2 in early tubular development induces nephrogenic diabetes insipidus.
Suzuki T; Seki S; Hiramoto K; Naganuma E; Kobayashi EH; Yamaoka A; Baird L; Takahashi N; Sato H; Yamamoto M
Nat Commun; 2017 Feb; 8():14577. PubMed ID: 28233855
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of COX-1, COX-2, and mPGES in rats with nephrogenic and central diabetes insipidus.
Kotnik P; Nielsen J; Kwon TH; Krzisnik C; Frøkiaer J; Nielsen S
Am J Physiol Renal Physiol; 2005 May; 288(5):F1053-68. PubMed ID: 15644490
[TBL] [Abstract][Full Text] [Related]
10. Systematic review and practical guideline for the prevention and management of the renal side effects of lithium therapy.
Schoot TS; Molmans THJ; Grootens KP; Kerckhoffs APM
Eur Neuropsychopharmacol; 2020 Feb; 31():16-32. PubMed ID: 31837914
[TBL] [Abstract][Full Text] [Related]
11. Atorvastatin in the treatment of Lithium-induced nephrogenic diabetes insipidus: the protocol of a randomized controlled trial.
Fotso Soh J; Torres-Platas SG; Beaulieu S; Mantere O; Platt R; Mucsi I; Saury S; Renaud S; Levinson A; Andreazza AC; Mulsant BH; Müller D; Schaffer A; Dols A; Cervantes P; Low NC; Herrmann N; Christensen BM; Trepiccione F; Rajji T; Rej S
BMC Psychiatry; 2018 Jul; 18(1):227. PubMed ID: 30012135
[TBL] [Abstract][Full Text] [Related]
12. Lithium-induced nephrogenic diabetes insipidus: new clinical and experimental findings.
Trepiccione F; Christensen BM
J Nephrol; 2010; 23 Suppl 16():S43-8. PubMed ID: 21170888
[TBL] [Abstract][Full Text] [Related]
13. Genetic deletion of ADP-activated P2Y
Zhang Y; Hansson KM; Liu T; Magnell K; Huang Y; Carlson NG; Kishore BK
Acta Physiol (Oxf); 2019 Feb; 225(2):e13191. PubMed ID: 30257062
[TBL] [Abstract][Full Text] [Related]
14. Cooperative mechanisms of acute antidiuretic response to bendroflumethiazide in rats with lithium-induced nephrogenic diabetes insipidus.
Moosavi SM; Haghani M
Can J Physiol Pharmacol; 2010 Dec; 88(12):1191-201. PubMed ID: 21164566
[TBL] [Abstract][Full Text] [Related]
15. RNA-Seq and protein mass spectrometry in microdissected kidney tubules reveal signaling processes initiating lithium-induced nephrogenic diabetes insipidus.
Sung CC; Chen L; Limbutara K; Jung HJ; Gilmer GG; Yang CR; Lin SH; Khositseth S; Chou CL; Knepper MA
Kidney Int; 2019 Aug; 96(2):363-377. PubMed ID: 31146973
[TBL] [Abstract][Full Text] [Related]
16. Cooperative mechanisms involved in chronic antidiuretic response to bendroflumethiazide in rats with lithium-induced nephrogenic diabetes insipidus.
Moosavi SM; Karimi Z
Acta Physiol Hung; 2014 Mar; 101(1):88-102. PubMed ID: 24631797
[TBL] [Abstract][Full Text] [Related]
17. Development of lithium-induced nephrogenic diabetes insipidus is dissociated from adenylyl cyclase activity.
Li Y; Shaw S; Kamsteeg EJ; Vandewalle A; Deen PM
J Am Soc Nephrol; 2006 Apr; 17(4):1063-72. PubMed ID: 16495377
[TBL] [Abstract][Full Text] [Related]
18. Sildenafil reduces polyuria in rats with lithium-induced NDI.
Sanches TR; Volpini RA; Massola Shimizu MH; Bragança AC; Oshiro-Monreal F; Seguro AC; Andrade L
Am J Physiol Renal Physiol; 2012 Jan; 302(1):F216-25. PubMed ID: 22031848
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, randomized, placebo-controlled pilot trial of atorvastatin for nephrogenic diabetes insipidus in lithium users.
Fotso Soh J; Beaulieu S; Trepiccione F; Linnaranta O; Torres-Platas G; Platt RW; Renaud S; Su CL; Mucsi I; D'Apolito L; Mulsant BH; Levinson A; Saury S; Müller D; Schaffer A; Dols A; Low N; Cervantes P; Christensen BM; Herrmann N; Rajji T; Rej S
Bipolar Disord; 2021 Feb; 23(1):66-75. PubMed ID: 32621644
[TBL] [Abstract][Full Text] [Related]
20. alphaENaC-mediated lithium absorption promotes nephrogenic diabetes insipidus.
Christensen BM; Zuber AM; Loffing J; Stehle JC; Deen PM; Rossier BC; Hummler E
J Am Soc Nephrol; 2011 Feb; 22(2):253-61. PubMed ID: 21051735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
